MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
Mukherjee N, Skees J, Todd KJ, West DA, Lambert KA, Robinson WA, Amato CM, Couts KL, Van Gulick R, MacBeth M, Nassar K, Tan AC, Zhai Z, Fujita M, Bagby SM, Dart CR, Lambert JR, Norris DA, Shellman YG.
Mukherjee N, et al. Among authors: todd kj.
Cell Death Dis. 2020 Jun 8;11(6):443. doi: 10.1038/s41419-020-2646-2.
Cell Death Dis. 2020.
PMID: 32513939
Free PMC article.